£110.40

Research Progress in Alzheimer's Disease and Dementia: v. 3 (Nova Biomedical): Volume 3

Price data last checked 53 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

About as cheap as it gets. The only time it was cheaper was 2 months ago.

£110 today · all-time low £109 (May 2026) · usually the usual

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 38 days · 38 data points (no recent data)

Historical
Generating forecast…
£113.23 £109.11 £110.01 £110.91 £111.81 £112.71 £113.61 23 April 2026 02 May 2026 11 May 2026 20 May 2026 30 May 2026

Price Distribution

Price distribution over 38 days • 3 price levels

Days at Price
Current Price
7 days 24 days · current 7 days 0 6 12 18 24 £109 £111 £113 Days at Price

Price Analysis

Most common price: £111 (24 days, 63.2%)

Price range: £109 - £113

Price levels: 3 different prices over 38 days

Description

Alzheimer's disease (AD), the most common form of neurodegenerative disorder in the elderly, is characterised pathologically by extracellular amyloid plaques and intracellular neurofibrillary tangles, pathophysiologically by synaptic dysfunction, and clinically by a progressive decline in cognition. Currently, AD has no cure and its prevalence is predicted to triple by 2050 with the rapid increase in the ageing population, unless more effective treatments are developed. Since the publication of the second book volume, the rapid progress in the research fields of AD and dementia continues through the intensive efforts of research scientists worldwide. This third book volume contains 15 chapters, bringing together a presentation of research frontiers in current AD/dementia research. The topics include molecular genetics of AD, gene expression abnormalities in AD progression, presenilins, taupathy in AD, single -induced(neuron gene expression abnormalities in AD, intracellular A neurodegeneration, roles of lipoprotein receptors in AD onset and progression, cholesterol and tau hyperphosphorylation, AD diagnostics and therapeutic strategies, in vivo visualisation of amyloid-like structures, cathepsin B, antiamyloidogenesis and neuroprotection, environmental enrichment, Fragile X mental retardation gene and dementia, category learning in Parkinson's disease, cerebrovascular disease and dementia, and dementia and hypertension. These chapters cover current advances in our understanding of the pathogenic mechanisms underlying AD and dementia, in the diagnosis of early AD and dementia, and in the development of therapeutic agents that target memory-relevant AD pathogenesis. The book will be highly valuable to students and scientists worldwide who are interested in the scientific research progress in AD and dementia.

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

Advances in Plasma Physics Research: v. 2: Vol 2: Volume 2
95% match

Advances in Plasma Physics Research: v. 2: Vol 2: Volume 2

£61.66 14 Jul 2026
Alzheimer's Disease: New Research (Nova Biomedical)
88% match

Alzheimer's Disease: New Research (Nova Biomedical)

£39.03 14 Jul 2026
Connections, Cognition and Alzheimer’s Disease (Research and Perspectives in Alzheimer's Disease)
84% match

Connections, Cognition and Alzheimer’s Disease (Research and Perspectives in Alzheimer's Disease)

Springer

£77.85 20 May 2026
Alzheimer’s Disease: A Physician’s Guide to Practical Management (Current Clinical Neurology)
84% match

Alzheimer’s Disease: A Physician’s Guide to Practical Management (Current Clinical Neurology)

Humana

£74.05 27 May 2026
Alzheimer's Disease: Advances in Genetics, Molecular and Cellular Biology
84% match

Alzheimer's Disease: Advances in Genetics, Molecular and Cellular Biology

Springer

£107.98 28 May 2026
Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers
83% match

Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers

Springer

£117.61 11 May 2026
Presenilins and Alzheimer’s Disease (Research and Perspectives in Alzheimer's Disease)
83% match

Presenilins and Alzheimer’s Disease (Research and Perspectives in Alzheimer's Disease)

Springer

£76.22 01 Jun 2026
Neuroimaging Diagnosis for Alzheimer's Disease and Other Dementias
82% match

Neuroimaging Diagnosis for Alzheimer's Disease and Other Dementias

Springer

£113.38 19 May 2026
Pathogenesis of Neurodegenerative Disorders (Contemporary Neuroscience)
82% match

Pathogenesis of Neurodegenerative Disorders (Contemporary Neuroscience)

Humana

£143.49 24 May 2026
Biomarkers for Alzheimer’s Disease Drug Development: 1750 (Methods in Molecular Biology, 1750)
82% match

Biomarkers for Alzheimer’s Disease Drug Development: 1750 (Methods in Molecular Biology, 1750)

Humana

£59.42 25 May 2026
Neurodegenerative Disorders: Loss of Function Through Gain of Function (Research and Perspectives in Alzheimer's Disease)
81% match

Neurodegenerative Disorders: Loss of Function Through Gain of Function (Research and Perspectives in Alzheimer's Disease)

Springer

£107.93 12 Jun 2026
Ageing and Dementia: 53 (Journal of Neural Transmission. Supplementa, 53)
81% match

Ageing and Dementia: 53 (Journal of Neural Transmission. Supplementa, 53)

Springer

£127.73 14 Jul 2026
Vascular Dementia: Cerebrovascular Mechanisms and Clinical Management (Current Clinical Neurology)
81% match

Vascular Dementia: Cerebrovascular Mechanisms and Clinical Management (Current Clinical Neurology)

Humana

£80.65 22 May 2026
Alzheimer's Disease: Methods and Protocols: 32 (Methods in Molecular Medicine, 32)
81% match

Alzheimer's Disease: Methods and Protocols: 32 (Methods in Molecular Medicine, 32)

Humana

£103.24 25 May 2026
Current Hypotheses and Research Milestones in Alzheimer's Disease
81% match

Current Hypotheses and Research Milestones in Alzheimer's Disease

Springer

£107.72 25 May 2026
Abeta Peptide and Alzheimer's Disease: Celebrating a Century of Research
80% match

Abeta Peptide and Alzheimer's Disease: Celebrating a Century of Research

Springer

£76.38 28 May 2026
Molecular Imaging of Neurodegenerative Disorders
80% match

Molecular Imaging of Neurodegenerative Disorders

Springer

£96.65 05 Jun 2026
Dementia (Perspectives on Individual Differences)
80% match

Dementia (Perspectives on Individual Differences)

Springer

£108.53 01 Jun 2026
Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future: 2 (Advances in Predictive, Preventive and Personalised Medicine, 2)
80% match

Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future: 2 (Advances in Predictive, Preventive and Personalised Medicine, 2)

Springer

£111.83 26 May 2026
Alzheimer's Disease and Other Dementias: A Practical Guide
80% match

Alzheimer's Disease and Other Dementias: A Practical Guide

Routledge

£51.57 14 May 2026
Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future: 2 (Advances in Predictive, Preventive and Personalised Medicine, 2)
80% match

Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future: 2 (Advances in Predictive, Preventive and Personalised Medicine, 2)

Springer

£108.75 14 Jun 2026
Neurodegenerative Disorders: A Clinical Guide
80% match

Neurodegenerative Disorders: A Clinical Guide

Springer

£60.42 26 May 2026
Studies on Alzheimer's Disease (Oxidative Stress in Applied Basic Research and Clinical Practice)
80% match

Studies on Alzheimer's Disease (Oxidative Stress in Applied Basic Research and Clinical Practice)

Humana

£107.98 04 Jun 2026
Alzheimer’s Disease. Epidemiology, Neuropathology, Neurochemistry, and Clinics (Key Topics in Brain Research)
80% match

Alzheimer’s Disease. Epidemiology, Neuropathology, Neurochemistry, and Clinics (Key Topics in Brain Research)

Springer

£50.88 26 May 2026